Human Papilloma Virus Vaccination Among Female Patients Attending French Pediatric Cystic Fibrosis Centers - 30/04/21
, Julie Haesebaert, MD, PhD 4, 5, Angélique Denis, PhD 6, Philippe Reix, MD, PhD 7, 8, Cathy Llerena, MD 9, Marie Perceval, MSc 1, Sandrine Touzet, MD, PhD 4, 6, Isabelle Durieu, MD, PhD 1, 4Abstract |
Study Objective |
To describe human papilloma virus (HPV) vaccination practice among adolescent girls with cystic fibrosis (CF) and to identify reasons for non-vaccination.
Design |
Cross-sectional multicentric study.
Setting and Participants |
Girls aged 9-17 years, attending 7 French pediatric CF centers, and their accompanying adult.
Interventions |
Administration of a self-report questionnaire.
Main Outcome Measures |
The proportion of girls having received or receiving HPV vaccination, compliance with the vaccination schedule, factors associated with vaccination, and reasons for vaccination and for non-vaccination.
Results |
A total of 113 girls and 104 accompanying adults participated. The mean age was 13.6 years (standard deviation 2.5; range 9-17). A total of 34 (30.9%) patients reported having received HPV vaccination. Among the 34 girls aged 15 years or older, 15 (44.1%) were vaccinated. Most patients (58.8%) started vaccination between 11 and 14 years of age (mean age 13.9). Most vaccine prescriptions (67.6%) were made by a CF center health care provider. Factors associated with vaccination were older age (odds ratio [OR] = 1.27, 95% confidence interval [CI] = 1.01-1.6, P = .037 for each year older), previous vaccination by the accompanying parent of one of their children for hepatitis B (OR = 8.01, 95% CI = 0.96-67.02), P = .055), and parental influence on decision-making (OR = 2.77, 95% CI = 0.97-7.95, P = .058). Health care providers’ positive advice and fear of HPV-related disease were the main reasons given to justify vaccination decisions. Insufficient knowledge and concerns about potential side effects were the main barriers.
Conclusion |
HPV vaccination remains insufficient among girls with CF. CF health care providers may play a crucial role in HPV vaccination acceptance, and their sensitization to cervical cancer prevention is mandatory.
El texto completo de este artículo está disponible en PDF.Key Words : Sexual health, Reproductive health, Cervical screening, Vaccination, Human papilloma virus
Esquema
| The authors declare that they have no conflicts of interest. |
|
| This work was supported by l’Association Gregory Lemarchal. |
Vol 34 - N° 3
P. 317-323 - juin 2021 Regresar al número
Artículo precedente
- Self-Concept, Depression, and Anxiety Levels of Adolescents with Polycystic Ovary Syndrome
- Habip Almis, Filiz ?im?ek Orhon, Semih Bolu, Behice Han Almis
- Frequency of Sexual Orientation and Gender Identity Documentation After Electronic Medical Record Modification
- Nancy Sokkary, Hamza Awad, Dillon Paulo
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?